Sign In
Buy SMMT
$15.07
+0.210 (+1.41%)
At Close: Jun 03, 2026
Summit Therapeutics to Present at Upcoming Investor Conferences
04:15pm, Tuesday, 26'th Nov 2024
MIAMI--(BUSINESS WIRE)---- $SMMT--Summit Therapeutics Inc. (NASDAQ: SMMT) (“Summit,” “we,” or the “Company”) today announced that it will participate in and present at the 7th Annual Everc
3 Monster Stocks in the Making
06:30am, Saturday, 23'rd Nov 2024
3 Monster Stocks in the Making
Summit Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:15pm, Thursday, 21'st Nov 2024
MIAMI--(BUSINESS WIRE)---- $SMMT--Summit Therapeutics Inc. (NASDAQ: SMMT) ("Summit," "we," or the "Company") today announced the grant of inducement awards of options to purchase a collective total of
2 Hot Biopharma Stocks to Buy and Hold for 5 Years
07:00am, Friday, 08'th Nov 2024
If you're patient, these businesses have a lot of promising projects in the works.
Why Summit Therapeutics Stock Was a Winner Today
06:56pm, Monday, 04'th Nov 2024
A cancer drug has vast potential for the company, says a pundit newly following it.
Summit Therapeutics 'Unique Investment In Oncology,' Lead Drug Candidate Shows Promise Over Keytruda And Opdivo
02:14pm, Monday, 04'th Nov 2024
JMP Securities initiated coverage on Summit Therapeutics Inc. SMMT, noting the company's initial focus on infectious disease. Later, in 2022, the company pivoted to oncology and in-licensed ivonescima
Summit Therapeutics: Is Their Lung Cancer Drug a Game Changer?
10:00am, Monday, 04'th Nov 2024
Summit Therapeutics Inc. NASDAQ: SMMT is a development-stage biotech company specializing in novel therapies for oncology and infectious diseases. Their leading drug candidate is Ivonescimab, an immun
3 Magnificent Stocks Under $100 to Buy in November
06:41am, Sunday, 03'rd Nov 2024
The price could be right for these stocks.
Summit Therapeutics Posts Wider-Than-Expected Loss in Q3, Nil Sales
09:46am, Thursday, 31'st Oct 2024
SMMT's third-quarter earnings miss estimates. Management also provides updates on the company's pipeline.
3 Stocks That Have Generated 1,000% Returns in Just 2 Years
08:29am, Thursday, 31'st Oct 2024
Should you add these fast-growing stocks to your portfolio?
Summit Therapeutics Inc. (SMMT) Q3 2024 Earnings Call Transcript
01:27pm, Wednesday, 30'th Oct 2024
Summit Therapeutics Inc. (NASDAQ:SMMT ) Q3 2024 Earnings Conference Call October 30, 2024 9:00 AM ET Company Participants Dave Gancarz - Chief Business and Strategy Officer Bob Duggan - Chairman and C
Summit Therapeutics Reports Operational Progress and Financial Results for the Third Quarter and Nine Months Ended September 30, 2024
07:00am, Wednesday, 30'th Oct 2024
MIAMI--(BUSINESS WIRE)---- $SMMT--Summit Therapeutics Inc. (NASDAQ: SMMT) ("Summit," "we," or the "Company") today reported an update on its operational progress and financial results for the third qu
Is Summit Therapeutics a Millionaire Maker?
02:29pm, Sunday, 27'th Oct 2024
The potential upside of this stock is undeniably meaty.
Summit Therapeutics Stock: Sell or Hold Before Q3 Earnings?
10:36am, Thursday, 24'th Oct 2024
Devoid of any marketed drug in its portfolio, investors will likely focus on SMMT's pipeline updates when it reports third-quarter results this month.
Up Over 600% in 2024, Can Summit Therapeutics Stock Keep Rising?
05:13am, Thursday, 24'th Oct 2024
This drugmaker's lead candidate could become a top-selling cancer therapy.
